TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial).
Tatsuya Ioka, Makoto Ueno, Hideki Ueno, Joon Oh Park, Heung-Moon Chang, Naoki Sasahira, Masashi Kanai, Ik Joo Chung, Masafumi Ikeda, Shoji Nakamori, Nobumasa Mizuno, Yasushi Omuro, Taketo Yamaguchi, Hiroki Hara, Kazuya Sugimori, Junji Furuse, Hiroyuki Maguchi, Masayuki Furukawa, Kengo Fukuzawa, Jun-Suk Kim, Seigo Yukisawa, Masahiro Takeuchi, Takuji Okusaka, Narikazu Boku, Ichinosuke Hyodo
European journal of cancer (Oxford, England : 1990) 2020;106():78-88